1131 Pediatric Constipation

Purpose

To evaluate the safety and efficacy of Lubiprostone 12 or 24 mcg twice daily compared to placebo.

Criteria

Contact Principal Investigator for Information

Details

Patients aged 6 - less than 18 years old with a diagnosis of functional constipation (average of less than 2 bowel movements per week.  Patient/guardian will keep an electronic diary to record constipation medication used and bowel habits daily.  Lab will be required at most visits. Patients that complete the study will have an option to participate in an extension study where placebo is not involved.

Interested in more information? Contact Us:

Sunny Hussain, M.D., Principal Investigator
(318) 212-8130

IRB: Quorum
IRB Number:
Trial Type: Drug
Sponsor: Sucampo